Key facts
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Guojian Yinuo
- ·The full record, as it builds
Funding rounds
No funding rounds for Guojian Yinuo are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Guojian Yinuo
Developer of cellular-based therapeutic equipment intended for oncology treatment purposes. The company offers immune cell engineering, automated production technologies, and proprietary research methods, enabling the biopharmaceutical market to access scalable, patent-backed innovations that support clinical development, enhance treatment precision, streamline manufacturing processes, and expand therapeutic options for cancer care through advanced biotechnology applications.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2019
- Employees
- 42
- Ownership
- Privately Held (backing)
Guojian Yinuo doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Guojian Yinuo shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Guojian Yinuo in its N-PORT filings yet. We sweep new filings monthly.